OTX-CSI improves dry eye signs, symptoms in phase 1 study
1 month ago - By Healio
OTX-CSI seems to be a safe treatment option for patients with dry eye disease, according to a speaker at the European Society of Cataract and Refractive Surgeons meeting.
“The OTX-CSI intracanalicular insert with cyclosporine improved signs and symptoms of dry eye disease as measured by change from baseline in Schirmer's test, corneal staining, dry eye disease severity and frequency scores, and dry eye disease symptom questionnaires,” Mitchell A. Jackson, MD, said.
The phase 1 study investigating OTX-CSI included five patients who had dry eye disease in
Read more ...
The headlines of Master Doctor